References
- Garvin IP. Remarks on pneumonia biliosa. South Med J Surg 1836; 1: 536–44.
- Haglund U. Systemic mediator release from gut in critical illness. Crit Care Med 1993; 21: 15–9.
- Hawker F. SIRS in the critically ill: is it a liver disease? Int J Intens Care 1994; I: 113.
- Roelofsen H, van der Veere CN, Ottenhoff R, Schoemaker B, Jansen PLM, Oude Elferink RPJ. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 1994; 107: 1075–84.
- Banks JG, Foulis AK, Ledingham IM, Macsween RNM. Liver function in septic shock. J Clin Pathol 1982; 35: 1249–52.
- Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280–7.
- Eriksson M, Lundkvist K, Drott P, Saldeen T, Eriksson O. Beneficial effects of pre treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. Acta Anaesthesiol Scand 1996; 40: 538–48.
- Eriksson M, Lundkvist K, Larsson A, Nelson D, Saldeen T, Drott P, Eriksson O. Vitamin A exerts potential therapeutic effects in a porcine model of endotoxaemia. Acta Anaesthesiol Scand 1997; 41: 824–924.
- Modig J. Adult respiratory distress syndrome. Comp Path Bull 1989; 21: 2–4.
- Lichtwarck-Ashoff M, Nielsen JB, Sjöstrand UH, Edgren EL. An experimental randomized study of five different ventilatory modes in a piglet model of severe respiratory distress. Intensive Care Med 1992; 18: 339–47.
- Vandermeer TJ, Menconi MJ, O’Sullivan BP, Larkin VA, Wang H, Kradin RL, Fine MP. Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia. J Appl Physiol 1994; 76: 2006–14.
- Freudenberg MA, Galanos C. Bacterial lipopolysaccharides: structure, metabolism and mechanism of action. Int Rev Immunol 1990; 6: 207–21.
- Mammen EF. Perspectives for the future. Immunol Today 1992; 13: 271–6.
- Fox ES, Broitman SA, Thomas P. Biology of disease: bacterial endotoxins and the liver. Lab Invest 1990; 63: 733–41.
- Van Bossuyt H, De Zanger RB, Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liner and its inactivation by bile salts. J Hepatol 1988; 7: 327–37.
- Nolan JP. Endotoxin, retriculoendothelial function, and liver injury. Hepatology 1981; 1: 458–65.
- Liao W, Floren C-H. Endotoxins inhibit endocytotic catabolism of low-density lipoproteins in Hep G2 cells. Hepatology 1992; 16: 224–31.
- Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245–61.
- Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor α decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 1995; 22: 1273–8.
- Greve JW, Gouma DJ, Buurman WA. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 1989; 10: 454–8.
- Pearson JM, Schultze AE, Jean PA, Roth RA. Platelet participation in liver injury from Gram-negative bacterial lipopolysaccharide in the rat. Shock 1995; 4: 178–86.
- Zinner MJ, Gurll NJ, Reynolds DG. The effects of endotoxinemia and fluid expansion on gastric hemodynamics and mucosal permeability in the baboon. J Surg Res 1977; 22: 606–10.
- Yokoyama I, Gavaler JS, Todo S, Miyata T, Van Thiel DH, Starzl TE. Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week. Hepatogastroenterology 1995; 42: 205–8.